Bill > SB927

This bill modifies the appointment procedures for the Medicaid Drug Utilization Review Board (DUR Board), which is part of the Oklahoma Health Care Authority. The bill makes several key changes to the board's composition and selection process: it adjusts the number of names required for physician nominations from six to three for the Oklahoma State Medical Association, changes "Pharmaceutical" to "Pharmacists" in the association name, and updates language referring to board members' state residency. The board will continue to consist of 10 members, including four physicians (three from the State Medical Association and one from the Osteopathic Association), four licensed pharmacists, one lay community representative with healthcare expertise, and one pharmaceutical industry representative. Board members will still serve three-year terms, with initial staggered two-year appointments for some members, and can be reappointed for up to three full terms plus one partial term. The bill maintains provisions for geographic balance in appointments and requires the board to comply with open meeting and administrative procedures. The bill will become effective on November 1, 2025, and primarily focuses on technical updates to the board's nomination and appointment processes.

Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=sb927&Session=2600